MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research

MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).

CYD-4-61 is a Bax Activator Used for Breast Cancer Research

Macrophages confer resistance to BET inhibition in triple-negative

MSAB is a Selective Inhibitor of Wnt/β-Catenin Signaling

The effects of pulvomycin on epithelial-mesenchymal transition

Blogs MedChemExpress

Ceritinib is a novel triple negative breast cancer therapeutic

EM127 is a SMYD3 Covalent Inhibitor

Afatinib is an Irreversible and Orally Active EGFR Family Inhibitor

Blogs MedChemExpress

MPT0E028, an Orally Active HDAC Inhibitor, Induces Apoptosis by Targeting HDAC and Akt

This woman with triple Q breast implants has spent over $1 million

Outcomes4Me on X: 🗓Our upcoming #AskTheExpert webinar will

Triple Positive Breast Cancer: Diagnosis, Treatment, and Outlook

This woman as triple Q breast implants - Yahoo Sports

Racial Disparities in Triple-Negative Breast Cancer Outcomes